Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis

Journal of Biochemistry

Volumn 156, Issue 2, 2014, Pages 73-83

  Hoshii, Takayuki ^a   Matsuda, Satoshi ^b   Hirao, Atsushi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Haematopoiesis; Leukemogenesis lymphopoiesis; MTORC1; MTORC2

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN DERIVATIVE; MTOR PROTEIN, HUMAN; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; B LYMPHOCYTE; CELL FATE; CELL LINEAGE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; LYMPHOPOIESIS; MACROPHAGE; MYELOID PROGENITOR CELL; NONHUMAN; PLEIOTROPY; PRE T LYMPHOCYTE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOGENESIS; LYMPHOID PROGENITOR CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOID PROGENITOR CELLS; LYMPHOPOIESIS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84905656219     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvu037     Document Type: Review

References (82)

1. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293
2. Takahara, T. and Maeda, T. (2013) Evolutionarily conserved regulation of TOR signalling. J. Biochem. 154, 1-10
3. Wullschleger, S., Loewith, R., and Hall, M.N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
4. Guertin, D.A. and Sabatini, D.M. (2007) Defining the role of mTOR in cancer. Cancer Cell 12, 9-22
5. Kang, S.A., Pacold, M.E., Cervantes, C.L., Lim, D., Lou, H.J., Ottina, K., Gray, N.S., Turk, B.E., Yaffe, M.B., and Sabatini, D.M. (2013) mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 341, 1236566
6. Kim, D.H., Sarbassov, D.D., Ali, S.M., Latek, R.R., Guntur, K.V., Erdjument-Bromage, H., Tempst, P., and Sabatini, D.M. (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895-904
7. Peterson, T.R., Laplante, M., Thoreen, C.C., Sancak, Y., Kang, S.A., Kuehl, W.M., Gray, N.S., and Sabatini, D.M. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886
8. Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K., Iemura, S., Natsume, T., and Mizushima, N. (2010) Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J. Biol. Chem. 285, 20109-20116
9. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189
10. Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D.M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175
11. Sancak, Y., Thoreen, C.C., Peterson, T.R., Lindquist, R.A., Kang, S.A., Spooner, E., Carr, S.A., and Sabatini, D.M. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-915
12. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A., and Hall, M.N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128
13. Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D.M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302
14. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y., Huang, Q., Qin, J., and Su, B. (2006) SIN1/ MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137
15. Pearce, L.R., Huang, X., Boudeau, J., Pawlowski, R., Wullschleger, S., Deak, M., Ibrahim, A.F., Gourlay, R., Magnuson, M.A., and Alessi, D.R. (2007) Identification of protor as a novel rictor-binding component of mTOR complex-2. Biochem. J. 405, 513-522
16. Thedieck, K., Polak, P., Kim, M.L., Molle, K.D., Cohen, A., Jeno, P., Arrieumerlou, C., and Hall, M.N. (2007) PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2, e1217
17. Thoreen, C.C., Chantranupong, L., Keys, H.R., Wang, T., Gray, N.S., and Sabatini, D.M. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113
18. Ganley, I.G., Lam du, H., Wang, J., Ding, X., Chen, S., and Jiang, X. (2009) ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol. Chem. 284, 12297-12305
19. Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S., Natsume, T., Takehana, K., Yamada, N., Guan, J.L., Oshiro, N., and Mizushima, N. (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981-1991
20. Peterson, T.R., Sengupta, S.S., Harris, T.E., Carmack, A.E., Kang, S.A., Balderas, E., Guertin, D.A., Madden, K.L., Carpenter, A.E., Finck, B.N., and Sabatini, D.M. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408-420
21. Hsu, P.P., Kang, S.A., Rameseder, J., Zhang, Y., Ottina, K.A., Lim, D., Peterson, T.R., Choi, Y., Gray, N.S., Yaffe, M.B., Marto, J.A., and Sabatini, D.M. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
22. Yu, Y., Yoon, S.O., Poulogiannis, G., Yang, Q., Ma, X.M., Villen, J., Kubica, N., Hoffman, G.R., Cantley, L.C., Gygi, S.P., and Blenis, J. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326
23. Hresko, R.C. and Mueckler, M. (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416
24. Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
25. Garcia-Martinez, J.M. and Alessi, D.R. (2008) mTOR complex 2 (mTORC2) controls hydrophobic motifphosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416, 375-385
26. Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., and Sabatini, D.M. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303
27. Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., and Sabatini, D.M. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501
28. Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., and Sabatini, D.M. (2011) mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334, 678-683
29. Demetriades, C., Doumpas, N., and Teleman, A.A. (2014) Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 156, 786-799
30. Menon, S., Dibble, C.C., Talbott, G., Hoxhaj, G., Valvezan, A.J., Takahashi, H., Cantley, L.C., and Manning, B.D. (2014) Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771-785
31. Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S., and Schreiber, S.L. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758
32. Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P., and Snyder, S.H. (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35-43
33. Sabers, C.J., Martin, M.M., Brunn, G.J., Williams, J.M., Dumont, F.J., Wiederrecht, G., and Abraham, R.T. (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270, 815-822
34. Sigal, N.H. and Dumont, F.J. (1992) Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10, 519-560
35. Lamming, D.W., Ye, L., Katajisto, P., Goncalves, M.D., Saitoh, M., Stevens, D.M., Davis, J.G., Salmon, A.B., Richardson, A., Ahima, R.S., Guertin, D.A., Sabatini, D.M., and Baur, J.A. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638-1643
36. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L., and Sabatini, D.M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB, Mol. Cell 22, 159-168
37. Yilmaz, O.H., Valdez, R., Theisen, B.K., Guo, W., Ferguson, D.O., Wu, H., and Morrison, S.J. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475-482
38. Lee, J.Y., Nakada, D., Yilmaz, O.H., Tothova, Z., Joseph, N.M., Lim, M.S., Gilliland, D.G., and Morrison, S.J. (2010) mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell 7, 593-605
39. Campbell, T.B., Basu, S., Hangoc, G., Tao, W., and Broxmeyer, H.E. (2009) Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation. Blood 114, 3392-3401
40. Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.L., Liu, Y., and Zheng, P. (2008) TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397-2408
41. Gan, B., Sahin, E., Jiang, S., Sanchez-Aguilera, A., Scott, K.L., Chin, L., Williams, D.A., Kwiatkowski, D.J., and DePinho, R.A. (2008) mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc. Natl Acad. Sci. U. S. A. 105, 19384-19389
42. Kalaitzidis, D., Sykes, S.M., Wang, Z., Punt, N., Tang, Y., Ragu, C., Sinha, A.U., Lane, S.W., Souza, A.L., Clish, C.B., Anastasiou, D., Gilliland, D.G., Scadden, D.T., Guertin, D.A., and Armstrong, S.A. (2012) mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell 11, 429-439
43. Magee, J.A., Ikenoue, T., Nakada, D., Lee, J.Y., Guan, K.L., and Morrison, S.J. (2012) Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Cell Stem Cell 11, 415-428
44. Huang, J., Nguyen-McCarty, M., Hexner, E.O., Danet-Desnoyers, G., and Klein, P.S. (2012) Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways. Nat. Med. 18, 1778-1785
45. Hoshii, T., Tadokoro, Y., Naka, K., Ooshio, T., Muraguchi, T., Sugiyama, N., Soga, T., Araki, K., Yamamura, K., and Hirao, A. (2012) mTORC1 is essential for leukemia propagation but not stem cell self-renewal. J. Clin. Invest. 122, 2114-2129
46. Guo, F., Zhang, S., Grogg, M., Cancelas, J.A., Varney, M.E., Starczynowski, D.T., Du, W., Yang, J.Q., Liu, W., Thomas, G., Kozma, S., Pang, Q., and Zheng, Y. (2013) Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis. Haematologica 98, 1353-1358
47. Hoshii, T., Kasada, A., Hatakeyama, T., Ohtani, M., Tadokoro, Y., Naka, K., Ikenoue, T., Ikawa, T., Kawamoto, H., Fehling, H.J., Araki, K., Yamamura, K.I., Matsuda, S., and Hirao, A. (2014) Loss of mTOR complex 1 induces developmental blockage in early Tlymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells. Proc. Natl Acad. Sci. U. S. A. 111, 3805-3810
48. Kueh, H.Y., Champhekar, A., Nutt, S.L., Elowitz, M.B., and Rothenberg, E.V. (2013) Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science 341, 670-673
49. Yang, C.S., Song, C.H., Lee, J.S., Jung, S.B., Oh, J.H., Park, J., Kim, H.J., Park, J.K., Paik, T.H., and Jo, E.K. (2006) Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cell. Microbiol. 8, 1158-1171
50. Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K.M., Kolbe, T., Stulnig, T.M., Horl, W.H., Hengstschlager, M., Muller, M., and Saemann, M.D. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577
51. Byles, V., Covarrubias, A.J., Ben-Sahra, I., Lamming, D.W., Sabatini, D.M., Manning, B.D., and Horng, T. (2013) The TSC-mTOR pathway regulates macrophage polarization. Nat. Commun. 4, 2834
52. Kellersch, B. and Brocker, T. (2013) Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. Blood 121, 298-307
53. Ohtani, M., Hoshii, T., Fujii, H., Koyasu, S., Hirao, A., and Matsuda, S. (2012) Cutting edge: mTORC1 in intestinal CD11c+ CD11b+ dendritic cells regulates intestinal homeostasis by promoting IL-10 production. J. Immunol. 188, 4736-4740
54. Wang, Y., Huang, G., Zeng, H., Yang, K., Lamb, R.F., and Chi, H. (2013) Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells. Proc. Natl Acad. Sci. U. S. A. 110, E4894-E4903
55. Zhang, S., Readinger, J.A., DuBois, W., Janka-Junttila, M., Robinson, R., Pruitt, M., Bliskovsky, V., Wu, J.Z., Sakakibara, K., Patel, J., Parent, C.A., Tessarollo, L., Schwartzberg, P.L., and Mock, B.A. (2011) Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 117, 1228-1238
56. Tang, F., Wu, Q., Ikenoue, T., Guan, K.L., Liu, Y., and Zheng, P. (2012) A critical role for Rictor in T lymphopoiesis. J. Immunol. 189, 1850-1857
57. Lee, K., Nam, K.T., Cho, S.H., Gudapati, P., Hwang, Y., Park, D.S., Potter, R., Chen, J., Volanakis, E., and Boothby, M. (2012) Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J. Exp. Med. 209, 713-728
58. Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B., Worley, P.F., Kozma, S.C., and Powell, J.D. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844
59. Delgoffe, G.M., Pollizzi, K.N., Waickman, A.T., Heikamp, E., Meyers, D.J., Horton, M.R., Xiao, B., Worley, P.F., and Powell, J.D. (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295-303
60. Kim, J.S., Sklarz, T., Banks, L.B., Gohil, M., Waickman, A.T., Skuli, N., Krock, B.L., Luo, C.T., Hu, W., Pollizzi, K.N., Li, M.O., Rathmell, J.C., Birnbaum, M.J., Powell, J.D., Jordan, M.S., and Koretzky, G.A. (2013) Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nat. Immunol. 14, 611-618
61. Yang, K., Shrestha, S., Zeng, H., Karmaus, P.W., Neale, G., Vogel, P., Guertin, D.A., Lamb, R.F., and Chi, H. (2013) T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 39, 1043-1056
62. Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., Magnuson, M.A., and Boothby, M. (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32, 743-753
63. Kurebayashi, Y., Nagai, S., Ikejiri, A., Ohtani, M., Ichiyama, K., Baba, Y., Yamada, T., Egami, S., Hoshii, T., Hirao, A., Matsuda, S., and Koyasu, S. (2012) PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Rep. 1, 360-373
64. Fingar, D.C., Richardson, C.J., Tee, A.R., Cheatham, L., Tsou, C., and Blenis, J. (2004) mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200-216
65. Dowling, R.J., Topisirovic, I., Alain, T., Bidinosti, M., Fonseca, B.D., Petroulakis, E., Wang, X., Larsson, O., Selvaraj, A., Liu, Y., Kozma, S.C., Thomas, G., and Sonenberg, N. (2010) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328, 1172-1176
66. Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., and Chi, H. (2013) mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499, 485-490
67. Park, Y., Jin, H.S., Lopez, J., Elly, C., Kim, G., Murai, M., Kronenberg, M., and Liu, Y.C. (2013) TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123, 5165-5178
68. Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.R., Luo, W., Zeller, K., Shimoda, L., Topalian, S.L., Semenza, G.L., Dang, C.V., Pardoll, D.M., and Pan, F. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772-784
69. Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R., and Chi, H. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376
70. Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., Larsen, C.P., and Ahmed, R. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112
71. Rao, R.R., Li, Q., Odunsi, K., and Shrikant, P.A. (2010) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32, 67-78
72. Finlay, D.K., Rosenzweig, E., Sinclair, L.V., Feijoo-Carnero, C., Hukelmann, J.L., Rolf, J., Panteleyev, A.A., Okkenhaug, K., and Cantrell, D.A. (2012) PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441-2453
73. Gubser, P.M., Bantug, G.R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B., Jauch, A., and Hess, C. (2013) Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14, 1064-1072
74. Lazorchak, A.S., Liu, D., Facchinetti, V., Di Lorenzo, A., Sessa, W.C., Schatz, D.G., and Su, B. (2010) Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Mol. Cell 39, 433-443
75. Calamito, M., Juntilla, M.M., Thomas, M., Northrup, D.L., Rathmell, J., Birnbaum, M.J., Koretzky, G., and Allman, D. (2010) Akt1 and Akt2 promote peripheral Bcell maturation and survival. Blood 115, 4043-4050
76. Amin, R.H. and Schlissel, M.S. (2008) Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9, 613-622
77. Kerdiles, Y.M., Beisner, D.R., Tinoco, R., Dejean, A.S., Castrillon, D.H., DePinho, R.A., and Hedrick, S.M. (2009) Foxo1 links homing and survival of naïve T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10, 176-184
78. Zhang, S., Pruitt, M., Tran, D., Du Bois, W., Zhang, K., Patel, R., Hoover, S., Simpson, R.M., Simmons, J., Gary, J., Snapper, C.M., Casellas, R., and Mock, B.A. (2013) B cell-specific deficiencies in mTOR limit humoral immune responses. J. Immunol. 191, 1692-1703
79. Benhamron, S. and Tirosh, B. (2011) Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells. Eur. J. Immunol. 41, 2390-2396
80. Sykes, S.M., Lane, S.W., Bullinger, L., Kalaitzidis, D., Yusuf, R., Saez, B., Ferraro, F., Mercier, F., Singh, H., Brumme, K.M., Acharya, S.S., Scholl, C., Tothova, Z., Attar, E.C., Frohling, S., DePinho, R.A., Armstrong, S.A., Gilliland, D.G., and Scadden, D.T. (2011) AKT/ FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697-708
81. Mills, J.R., Hippo, Y., Robert, F., Chen, S.M., Malina, A., Lin, C.J., Trojahn, U., Wendel, H.G., Charest, A., Bronson, R.T., Kogan, S.C., Nadon, R., Housman, D.E., Lowe, S.W., and Pelletier, J. (2008) mTORC1 promotes survival through translational control of Mcl-1. Proc. Natl Acad. Sci. U. S. A. 105, 10853-10858
82. Zhang, F., Lazorchak, A.S., Liu, D., Chen, F., and Su, B. (2012) Inhibition of the mTORC2 and chaperone pathways to treat leukemia. Blood 119, 6080-6088